AU2001233080A1 - Modulation of tolerance by altering nfat signalling - Google Patents

Modulation of tolerance by altering nfat signalling

Info

Publication number
AU2001233080A1
AU2001233080A1 AU2001233080A AU3308001A AU2001233080A1 AU 2001233080 A1 AU2001233080 A1 AU 2001233080A1 AU 2001233080 A AU2001233080 A AU 2001233080A AU 3308001 A AU3308001 A AU 3308001A AU 2001233080 A1 AU2001233080 A1 AU 2001233080A1
Authority
AU
Australia
Prior art keywords
altering
tolerance
modulation
nfat signalling
nfat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233080A
Inventor
Patrick G. Hogan
Anjana Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immune Disease Institute Inc
Original Assignee
BLOOD RES CENTER
Immune Disease Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BLOOD RES CENTER, Immune Disease Institute Inc filed Critical BLOOD RES CENTER
Publication of AU2001233080A1 publication Critical patent/AU2001233080A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
AU2001233080A 2000-01-27 2001-01-29 Modulation of tolerance by altering nfat signalling Abandoned AU2001233080A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17839900P 2000-01-27 2000-01-27
US60178399 2000-01-27
PCT/US2001/002850 WO2001055349A1 (en) 2000-01-27 2001-01-29 Modulation of tolerance by altering nfat signalling

Publications (1)

Publication Number Publication Date
AU2001233080A1 true AU2001233080A1 (en) 2001-08-07

Family

ID=22652404

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233080A Abandoned AU2001233080A1 (en) 2000-01-27 2001-01-29 Modulation of tolerance by altering nfat signalling

Country Status (2)

Country Link
AU (1) AU2001233080A1 (en)
WO (1) WO2001055349A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050079496A1 (en) * 2001-08-17 2005-04-14 Edgar Serfling Methods for diagnosing and treating neoplasias using nf-at transcriptions factors
US20050048585A1 (en) * 2002-12-13 2005-03-03 Irm Llc, A Delaware Limited Liability Company Methods and compositions for modulating NF-AT transcription factor
WO2007013358A2 (en) * 2005-07-28 2007-02-01 Oncotherapy Science, Inc. Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
DE09780481T1 (en) * 2008-07-11 2012-01-26 Medizinische Universität Innsbruck AGONISTS OF NR2F6 FOR IMMUNE UPPRESSION
WO2013070943A2 (en) * 2011-11-08 2013-05-16 Children's Medical Center Corporation Small molecule screen for inhibitors of nfat:ap-1:dna interactions
CN112458149B (en) * 2020-12-03 2021-10-08 北京东方百泰生物科技股份有限公司 Method for detecting activation degree of antibody drug on T cells by taking CD3 as target

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656067A4 (en) * 1991-08-22 1995-10-25 Univ Leland Stanford Junior Screening methods for immunosuppressive agents.
US6197925B1 (en) * 1991-08-22 2001-03-06 Sara Lee Corporation NF-AT polypeptides and polynucleotides
US5656452A (en) * 1993-01-15 1997-08-12 President And Fellows Of Harvard College NF-ATp, ' a T lymphocyte DNA-binding protein

Also Published As

Publication number Publication date
WO2001055349A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
AU2001238513A1 (en) Lubricated seals having micropores
AU2002213467A1 (en) Modulation of ccr4 function
AU2001262507A1 (en) Switching system
AU2002365827A1 (en) Havi-upnp bridging
AU2001295758A1 (en) Seal
AU2001290777A1 (en) Intelligent voice bridging
AU2002348909A1 (en) Havi-upnp bridging
AU2002230585A1 (en) Switching system
AU2531301A (en) Emergency lighting
AU2001292786A1 (en) Sulfur-containing cathode
AU2002212445A1 (en) Signalling means
AU2001233080A1 (en) Modulation of tolerance by altering nfat signalling
AU2001271426A1 (en) Modulation of apoptosis
AU2002223761A1 (en) Thickening composition
AU2002211150A1 (en) Traffic signalling
AUPR626701A0 (en) Switching assembly
AU5508201A (en) Moebius train
AU2002328209A1 (en) Hierarchical modulation
AU2001278591A1 (en) Switch assembly
AU2000268585A1 (en) Phase modulator
AU2001256507A1 (en) Modulation
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002313571A1 (en) Fm modulator
AU2001274253A1 (en) Signal modulation
AU7369701A (en) Lighting assembly